Chronic Hand Eczema: Perception and Knowledge in Non-affected Individuals from General and Dermatological Practice by Letule, Valerie et al.
Acta Derm Venereol 94
CLINICAL REPORT
Acta Derm Venereol 2014; 94: 687–690
© 2014 The Authors. doi: 10.2340/00015555-1816
Journal Compilation © 2014 Acta Dermato-Venereologica. ISSN 0001-5555
Misunderstanding and stigmatisation are common pro-
blems encountered by patients with hand eczema. Va-
rious misconceptions about the disease circulate in the 
general population. Although hand eczema has gained 
more attention in dermatology during the past years, in-
formation on public perception of the disease is still lack-
ing. The aim of our study was to investigate perception 
of and level of knowledge on the subject hand eczema. 
There were 624 patients included from 2 general medici-
ne practices and 2 dermatological practices. A self-admi-
nistered questionnaire was filled out by the participants, 
covering issues on history of hand eczema, level of know-
ledge and attitude towards a clinical photograph of hand 
eczema. We found that a larger proportion of individuals 
from dermatological practice were more familiar with 
hand eczema as a disease than those from general medi-
cal practice. Women knew significantly more about and 
had a more positive perception of the disease than men. 
Our results imply that the level of knowledge on hand 
eczema in the general public is rather low and influenced 
by prejudice. Key words: hand eczema; public awareness; 
level of knowledge; perception; stigmatisation; prejudice.
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Chronic hand eczema (CHE) is a common skin disease 
with an estimated one-year prevalence of up to 10% (1, 
2). As a clinically heterogeneous disease it presents with 
many different aetiologies and morphologies (3, 4). There-
fore, classification of hand eczema is challenging, as is 
the management of this chronic and relapsing disease (5).
The hands play a fundamental part in our everyday 
activities and social interactions (6). Therefore it is easy 
to understand why patients with chronic hand eczema 
are strongly impaired by their disease and suffer a lot 
from stigmatisation. Pain and itch further aggravate the 
burden of disease and add to the huge negative impact 
on the quality of life. 
In the last few years, interest in CHE began to grow 
when scientific research and knowledge about its 
pathogenesis and epidemiology increased. With new 
therapeutic options (5) and several new national guide-
lines on the management of hand eczema (4, 7–10) the 
disease became more and more a centre of interest in 
dermatology. In addition, CHE is the most common oc-
cupational disease and therefore of high socioeconomic 
impact (11, 12). Health-related costs and quality of life 
in CHE have also been investigated in several studies 
during the past years (13–16). It has become clear that 
prevention of this costly and disabling disease is an 
issue of great importance.
There are several studies looking at the awareness and 
level of knowledge in CHE patients or in occupations 
with high risk for developing hand eczema (17–20). A 
common approach of these studies is the use of ques-
tionnaires to investigate the level of perception of the 
disease as well as the knowledge of prevention in cohorts 
especially at risk, such as hairdressers (17) and health care 
workers (18, 19). These studies were aimed predomina-
tely at the targeted prevention in exposed individuals.
Research data on the knowledge of CHE in the general 
population beyond risk cohorts is, however, lacking. To 
date, there are no studies investigating the perception of 
CHE in non-affected individuals. Many patients report a 
lack of understanding and tolerance in the environment 
they have to face every day, and how they often feel re-
jected by their peers. In order to raise public awareness, 
improve acceptance and reduce stigmatisation for CHE 
patients, specific educational work is necessary. The aim of 
this study was to investigate the perception of CHE in the 
general public by a short self-administered questionnaire.
METHODS
The study was designed as a cross-sectional study. Patients 
visiting a general medical practice irrespective of the reason 
why they came, were chosen as cohort representative of the 
general population. Their results were compared to those from 
patients from dermatological practice. The ratio of patients of 
both medical specialities was intended to be 1:1, with a num-
ber of approximately 300 participants for each group. A short 
one-page self-administered questionnaire was sent to 4 private 
practices in Germany, 2 of them being general medical or in-
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ternal medicine practices and 2 of them being dermatological 
practices. All men and women over the age of 18 were eligible 
to participate randomly, regardless of the reason for consulting 
their physician. While sitting in the waiting room, patients were 
filling out the anonymous questionnaire for self-administration. 
The questionnaires were sent back to the study centre, where they 
were analysed. Sources of potential bias in this cross-sectional 
questionnaire study were manifold and had been taken into ac-
count. Questionnaires with a huge amount of missing data led 
to the exclusion of the subject from the study. 
The questionnaire consisted of 10 questions, which are shown 
in Table I. The possible answers were: yes, no, prior, 1–5, 5–10 
and > 10. At first, subjects gave short general information about 
their gender and age. They were then asked about their history of 
hand eczema and atopic disorders. In a third part they provided 
information about their perception of CHE in general and their 
attitude towards a clinical photograph of severe hand dermatitis 
in particular (Fig. 1). Finally, they estimated the prevalence of 
CHE in the general population.
The study was approved by the local ethics committee and 
carried out in accordance with the principles of the Declara-
tion of Helsinki.
Statistics
Statistical analysis was performed by bilateral analysis using 
χ²-test. p < 0.05 was considered to be statistically significant. 
Due to the explorative character of our study, p-values are cited 
without correction for multiple testing. The significant results 
of this investigation have primarily an explorative quality. 
RESULTS
Characterisation of the collective
In total, 624 subjects participated in the study, 52.9% 
(n = 330) were women and 44.9% (n = 280) were men; 
2.2% (n = 14) provided no information about their gender. 
The range of age was 18–88 years (mean age 52 years).
Forty-seven percent (n = 293; n1 = 67, n2 = 226) were 
patients from 4 general medical/internal medicine 
practice, and 53% (n = 331; n3 = 225, n4 = 106) from 2 
dermatological practices. A total of 13.3% (n = 83) had a 
history of hand eczema with 6.6% (n = 41) having hand 
eczema at time of questioning and 6.7% (n = 42) having 
had hand eczema previously (i.e. before questioning). Of 
the subjects, 22.6% (n = 141) had active atopic disorders 
at time of questioning, 3.5% (n = 22) before that time 
and 72.9% (n = 455) had no history of atopic disorders 
at all. Hand cream was used routinely by 58% (n = 362) 
of the participants. Looking at the clinical photograph 
of the CHE patient, 45.4% (n = 283) of all subjects felt 
disgusted, 53.2% (n = 332) did not, and 1.4% (n = 9) 
subjects refused to answer the question. Only 33.8% 
(n = 211) of the participants would shake hands with 
the patient from the photograph, whilst 63.3% (n = 395) 
would refuse to do so; 2.9% (n = 18) did not answer 
this question. Of the participants, 34.9% (n = 218) sus-
pected the skin lesions to be infectious whereas 62.5% 
(n = 390) did not think so and 2.6% (n = 16) did not give 
any information. The prevalence of hand eczema was 
estimated by the subjects as follows: 1–5% prevalence: 
29.2% (n = 182) , 5–10% prevalence: 38.8% (n = 242), 
and > 10% prevalence: 29.9% (n = 187). The question 
was not answered by 2.1% (n = 13). Table II gives an 
overview on the data from the following paragraphs.
Results from general medical/internal medicine practice 
compared to dermatological practice 
Only 57.7% (169/293) of the individuals from general 
medical practices knew about the disease entity CHE 
compared to 66.2% (219/331) of the subjects from 
dermatological practices (p < 0.05; 95% CI 1.02–2.01).
none of the other features of the questionnaire reached 
statistical significance when comparing the 2 cohorts.
Differences between female and male participants
Of all 388 participants knowing about hand eczema, 
57.7% (n = 224) were female and 40.2% (n = 156) male 
Table I. The questionnaire consisted of 10 questions on general 
information, history of hand eczema and atopic disorders and 
perception of hand eczema. Questions 7–9 refer to a clinical picture 
of a patient with hand eczema
Question Answer
Gender Male/female
Do you know what hand eczema is? Yes/no
Do you yourself suffer from hand eczema? Yes/no/prior
Do you have hay fever, flexural eczema or 
allergic asthma?
Yes/no/prior
Do you use hand cream regularly? Yes/no
If you use hand cream regularly, how often 
per day?
1–5 times/5–10 times/day
Would you shake hands with this person? Yes/no
Do you think that this skin disease is 
contagious?
Yes/no
Do you feel disgusted by these hands? Yes/no
What is your estimation about the prevalence 
of this disease?
1–5%/5–10%/>10%
Fig. 1. Clinical picture of a patient with severe hand eczema shown to 
the participants.
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(p < 0.05; 95% CI 1.19–2.37). Women were more fre-
quently using hand cream than men [76.4% (252/330) 
compared to 36.8% (103/280); p < 0.05; 95% CI 3.85–
8.02]. Female participants knowing about hand eczema 
were using cream more frequently than their male 
counterparts [female: 76.3% (171/224) male: 35.9% 
(56/156); p < 0.05; 95% CI 3.59–9.27]. Men suspected 
the disease more often to be infectious [43.2% (121/280) 
compared to 28.5% (94/330) for women; p < 0.05; 95% 
CI 1.35–2.71]. Women would agree to hand shaking 
more often than men [40.3% (133/330) compared to 
31.8% (89/280); p < 0.05; 95% CI 1.02–2.05].
Participants with or without history of hand eczema
Compared to participants without history of hand 
eczema, women were significantly more frequent in 
the group of participants with history of hand eczema 
[70.3% (57/81) vs 51.8% (269/519); p < 0.05; 95% CI 
1.29–3.78], as were individuals with a history of atopic 
disorders [43.4% (36/83) compared to 21% (111/329); 
p < 0.05; 95% CI 1.69–4.72].
Participants with history of hand eczema were using 
hand cream significantly more frequently than those 
without CHE history [69.9% (58/83) compared to 56.1% 
(297/529); p < 0.05; 95% CI 1.07–3.08]. They also knew 
more about their disease than non-affected participants 
[92.8% (77/83) vs. 58.8% (311/329); p < 0.05; 95% CI 
3.66–23.13].
Participants who had previously suffered from hand 
eczema themselves were significantly less convinced 
that the skin lesions on the clinical photograph might 
be infectious (20.5%; 17/83) than those without history 
of hand eczema [37.6% (199/529); p < 0.05; 95% CI 
1.30–4.31]. In addition, they were also more likely to 
shake hands with the patient from the picture [50% 
(40/80) compared to 32.1% (170/529); p < 0.05; 95% CI 
1.18–3.18]. When asked about their estimation of CHE 
prevalence, individuals with history of hand eczema 
rated more correctly than those without; they signifi-
cantly knew more often that CHE is very frequent and 
less often considered CHE a rare disease (see Table II). 
no differences were found comparing feeling of disgust 
towards hand eczema.
DISCUSSIOn
The aim of this study was to investigate the level of 
knowledge on CHE in the general population. As far 
as we know, this is the first study addressing this topic.
Subjects from dermatological practice knew signi-
ficantly more about CHE compared to subjects from 
general medical/internal medicine practice. Moreover, 
female participants knew more frequently what CHE 
is than male participants. They also would agree more 
likely to hand shaking with an affected individual and 
did not suspect the disease to be infectious as often as 
did men. 
Approximately 1/5 (20.5%) of subjects with history 
of hand eczema considered the disease to be contagious. 
Although this was significantly less frequent than parti-
cipants without CHE history, it shows that some patients 
are not properly informed about their disease. The fact 
that 7.2% of participants with CHE history negated 
knowledge on hand eczema supports this impression.
Compared to the participants that had never them-
selves suffered from HE before, those individuals with 
experience in hand eczema more often agreed in hand 
shaking with the patient from clinical picture, but, inte-
restingly, showed the same disgust towards the disease 
as the prior group.
These results suggest that individuals who have some 
kind of pre-knowledge on CHE might be less prejudiced 
towards the disease, but still educational work needs 
to be done.
Our study design has several limitations: though the 
cohorts can be seen as a cross-section from the general 
Table II. Results of questionnaire in the patient collective
Indicators



















Females 56.3 (183) 51.6 (147) 70.4 (57) 51.8 (269) Not significant p < 0.05
Males 43.7 (142) 48.4 (138) 29.6 (24) 48.2 (250)
knowledge of HE 66.2 (219) 57.7 (169) 92.8 (77) 58.8 (311) p < 0.05 p < 0.05
History of HE 15.1 (50) 11.3 (33) 100 (83) 0 (0) – Not significant
Subjects using hand cream 54.7 (181) 61.8 (181) 69.9 (58) 56.1 (297) Not significant p < 0.05
History of atopic disorders 26.3 (87) 25.9 (76) 43.4 (36) 21.0 (111) Not significant p < 0.05
Subjects feeling disgust 42.6 (141) 48.5 (142) 47 (39) 44.8 (237) Not significant Not significant
Subjects agreeing in hand shaking 35 (116) 32.4 (95) 50 (40) 32.1 (170) Not significant p < 0.05
Subjects suspecting the disease to be infectious 32.6 (108) 37.5 (110) 20.5 (17) 37.6 (199) Not significant p < 0.05
1–5% prevalence 27.8 (90) 32.1 (92) 16 (13) 32 (167) Not significant p < 0.05
5–10% prevalence 42.9 (139) 35.8 (103) 38.3 (31) 39.7 (207) Not significant
>10% prevalence 29.3 (95) 32.1 (92) 45.7 (37) 28.3 (148) p < 0.05
Total n = 331a n = 293a n = 83a n = 529a – –
aTotal numbers for different indicators vary, because not all participants gave answer to all questions. HE; hand eczema. 
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population regarding gender and age distribution, the 
sample size is relatively small. In addition, the answers 
of the participants have a subjective character. 
Patients with different chronic skin diseases, like 
psoriasis and atopic dermatitis, experience social rejec-
tion by their peers or have to face misunderstanding and 
prejudice. There are several studies that investigate the 
awareness of those patients (21–24) but information on 
disease perception of non-affected individuals is lack-
ing. Studies on this issue would be required in order to 
detect knowledge gaps and perform targeted educational 
work for improving tolerance. Such data have become 
available for a number of non-dermatological condi-
tions, e.g. HIV infection (25–27).
Our results implicate that the level of knowledge on 
hand eczema in the general public is low and affected 
by prejudice. In addition, the general perception of the 
disease shows a gender-specific difference, and depends 
on the amount of previous knowledge on the subject. 
This leads to the conclusion that a better knowledge on 
hand eczema might help to reduce intolerance and in 
consequence improve health-related quality of life in 
patients with CHE.
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